108_CD Alliance_NNP UniChem_NNP Plc_NNP Notes_NNP to_TO the_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD 47_CD RELATED_VBN PARTY_NN DISCLOSURES_NNS CONTINUED_VBD Key_NNP management_NN remuneration_NN The_DT remuneration_NN of_IN the_DT executive_NN Directors_NNS ,_, who_WP are_VBP the_DT key_JJ management_NN personnel_NNS of_IN the_DT Group_NNP ,_, is_VBZ set_VBN out_RP below_IN in_IN aggregate_NN for_IN each_DT of_IN the_DT categories_NNS specified_VBN by_IN IAS_NNP 24_CD Related_NNP Party_NNP Disclosures_NNS ._.
Further_JJ information_NN regarding_VBG the_DT individual_JJ remuneration_NN of_IN individual_JJ Directors_NNS is_VBZ provided_VBN in_IN the_DT Board_NNP report_NN on_IN remuneration_NN ._.
2005_CD 2004_CD million_CD million_CD Short-term_JJ employee_NN benefits_NNS 3.8_CD 3.7_CD Post-employment_NN benefits_NNS 1.1_CD 0.6_CD Other_JJ long-term_JJ benefits_NNS Termination_NN benefits_NNS 0.5_CD 0.8_CD Share-based_JJ compensation_NN charge_NN 2.1_CD 0.8_CD 7.5_CD 5.9_CD 48_CD CONTINGENT_NNP LIABILITIES_NNP The_NNP Group_NNP offers_VBZ its_PRP$ UK_NNP wholesale_JJ customers_NNS access_NN to_TO long-term_JJ financing_NN for_IN their_PRP$ pharmacy_NN businesses_NNS through_IN financing_VBG arrangements_NNS developed_VBN by_IN the_DT Group_NNP with_IN its_PRP$ banks_NNS ._.
The_DT Company_NN supports_VBZ these_DT arrangements_NNS through_IN the_DT provision_NN of_IN guarantees_NNS ,_, which_WDT at_IN 31_CD December_NNP 2005_CD amounted_VBD to_TO 19.6_CD million_CD 2004_CD 18.6_CD million_CD ._.
The_DT Group_NNP has_VBZ written_VBN a_DT number_NN of_IN guarantees_NNS in_IN relation_NN to_TO third_JJ party_NN funding_NN arrangements_NNS with_IN subsidiaries_NNS ._.
These_DT guarantees_NNS can_MD only_RB be_VB exercised_VBN by_IN the_DT lender_NN in_IN the_DT event_NN of_IN predefined_JJ events_NNS all_DT of_IN which_WDT reflect_VBP financial_JJ risks_NNS ._.
Therefore_RB these_DT agreements_NNS are_VBP accounted_VBN for_IN under_IN IAS_NNP 37_CD ._.
Guarantees_NNS are_VBP also_RB provided_VBN by_IN another_DT Group_NNP company_NN that_WDT totalled_VBD 11.3_CD million_CD at_IN 31_CD December_NNP 2005_CD 2004_CD 30.7_CD million_CD ._.
Total_JJ loans_NNS outstanding_JJ through_IN these_DT financing_VBG arrangements_NNS at_IN 31_CD December_NNP 2005_CD were_VBD 205.6_CD million_CD 2004_CD 205.8_CD million_CD ._.
On_IN 31_CD December_NNP 2005_CD the_DT total_JJ extent_NN of_IN these_DT guarantees_NNS amounted_VBD to_TO 30.9_CD million_CD 2004_CD 49.3_CD million_CD ._.
In_IN the_DT last_JJ five_CD years_NNS the_DT Group_NNP has_VBZ not_RB suffered_VBN any_DT loss_NN in_IN relation_NN to_TO these_DT schemes_NNS ._.
49_CD POST_NN BALANCE_NN SHEET_NN EVENTS_NNS On_IN 17_CD February_NNP 2006_CD the_DT Group_NNP announced_VBD that_IN it_PRP had_VBD reached_VBN an_DT agreement_NN to_TO enter_VB the_DT Russian_JJ pharmaceutical_JJ wholesale_JJ market_NN through_IN the_DT acquisition_NN of_IN a_DT 96_CD %_NN controlling_VBG stake_NN in_IN A._NN P._NNP Apteka_NNP Holding_NNP Limited_NNP ,_, the_DT parent_NN company_NN of_IN Apteka_NNP Holding_NNP ZAO_NNP ,_, for_IN a_DT consideration_NN of_IN approximately_RB 18_CD million_CD ._.
In_IN addition_NN the_DT Group_NNP will_MD assume_VB approximately_RB 10_CD million_CD of_IN net_JJ debt_NN ._.
The_DT Group_NNP will_MD have_VB an_DT option_NN to_TO acquire_VB the_DT remaining_VBG 4_CD %_NN of_IN A._NN P._NNP Apteka_NNP Holding_NNP Limited_NNP within_IN three_CD to_TO six_CD years_NNS ._.
The_DT transaction_NN ,_, which_WDT is_VBZ conditional_JJ upon_IN receiving_VBG regulatory_JJ approval_NN ,_, is_VBZ expected_VBN to_TO be_VB completed_VBN by_IN the_DT end_NN of_IN March_NNP 2006_CD ._.
50_CD TRANSITION_NNP TO_TO IFRS_NNP All_NNP references_NNS to_TO UK_NNP GAAP_NNP in_IN this_DT note_NN are_VBP to_TO UK_NNP GAAP_NNP applicable_JJ for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD ._.
This_DT is_VBZ the_DT first_JJ year_NN that_IN the_DT Group_NNP has_VBZ presented_VBN its_PRP$ financial_JJ statements_NNS under_IN IFRS_NNP ._.
The_DT last_JJ financial_JJ statements_NNS under_IN UK_NNP GAAP_NNP were_VBD for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD and_CC the_DT date_NN of_IN transition_NN to_TO IFRS_NNP was_VBD 1_CD January_NNP 2004_CD ._.
On_IN 18_CD July_NNP 2005_CD ,_, the_DT Group_NNP published_VBD detailed_JJ income_NN statement_NN and_CC balance_NN sheet_NN reconciliations_NNS of_IN UK_NNP GAAP_NNP to_TO IFRS_NNP ._.
The_DT following_NN is_VBZ an_DT abridged_JJ extract_VB of_IN the_DT published_VBN document_NN describing_VBG the_DT effects_NNS of_IN adoption_NN of_IN IFRS_NNP and_CC the_DT reconciliations_NNS required_VBN in_IN the_DT year_NN of_IN transition_NN ._.
Summary_NN of_IN the_DT effects_NNS of_IN IFRS_NNP adoption_NN The_DT principal_JJ impacts_NNS of_IN IFRS_NNP on_IN the_DT Groups_NNS 2004_CD financial_JJ statements_NNS were_VBD as_IN follows_VBZ :_: recognition_NN of_IN a_DT charge_NN for_IN the_DT fair_JJ value_NN of_IN share-based_JJ compensation_NN :_: requirement_NN not_RB to_TO amortise_VB goodwill_NN :_: recognition_NN of_IN deferred_VBN taxation_NN liabilities_NNS on_IN pharmacy_NN licences_NNS ,_, unremitted_JJ earnings_NNS of_IN associates_NNS and_CC rolled_VBD over_IN capital_NN gains_NNS :_: and_CC recognition_NN of_IN dividends_NNS only_RB when_WRB they_PRP are_VBP declared_VBN rather_RB than_IN when_WRB proposed_VBN ._.
In_IN terms_NNS of_IN the_DT 2004_CD results_NNS ,_, reported_VBD profits_NNS increased_VBN under_IN IFRS_NNP ,_, mainly_RB because_IN of_IN the_DT reversal_NN of_IN goodwill_NN amortisation_NN and_CC the_DT reversal_NN of_IN goodwill_NN recycled_VBN from_IN reserves_NNS on_IN the_DT disposal_NN of_IN subsidiaries_NNS ._.
Impact_NN on_IN profit_NN Excluding_VBG goodwill_NN amortisation_NN ,_, the_DT profit_NN on_IN disposal_NN of_IN subsidiaries_NNS and_CC amounts_NNS written_VBN off_RP investments_NNS ,_, the_DT effect_NN of_IN adoption_NN of_IN IFRS_NNP was_VBD not_RB significant_JJ ._.
The_DT Group_NNP considers_VBZ the_DT measurement_NN of_IN profit_NN excluding_VBG these_DT items_NNS to_TO be_VB a_DT useful_JJ indication_NN of_IN underlying_VBG performance_NN ._.
The_DT reduction_NN in_IN profits_NNS as_IN a_DT result_NN of_IN the_DT requirement_NN to_TO recognize_VB a_DT charge_NN for_IN the_DT fair_JJ value_NN of_IN share-based_JJ compensation_NN awards_NNS was_VBD largely_RB offset_VBN by_IN the_DT net_JJ credit_NN arising_VBG from_IN the_DT movements_NNS in_IN deferred_JJ taxation_NN liabilities_NNS recognized_VBN on_IN unremitted_JJ earnings_NNS of_IN associates_NNS ,_, pharmacy_NN licences_NNS and_CC rolled_VBD over_IN capital_NN gains_NNS ._.
Impact_NN on_IN net_JJ assets_NNS Net_JJ assets_NNS at_IN 31_CD December_NNP 2004_CD decreased_VBN under_IN IFRS_NNP ._.
This_DT was_VBD predominantly_RB due_JJ to_TO the_DT recognition_NN of_IN additional_JJ deferred_VBN taxation_NN liabilities_NNS under_IN IFRS_NNP as_IN a_DT general_JJ principle_NN ,_, the_DT recognition_NN of_IN deferred_VBN taxation_NN liabilities_NNS is_VBZ more_RBR comprehensive_JJ under_IN IFRS_NNP than_IN UK_NNP GAAP_NNP ._.
Partially_RB offsetting_VBG this_DT reduction_NN in_IN net_JJ assets_NNS was_VBD the_DT reversal_NN of_IN the_DT 2004_CD goodwill_NN amortisation_NN charge_NN and_CC the_DT accrual_NN for_IN the_DT proposed_VBN 2004_CD final_JJ dividend_NN ._.
109_CD Alliance_NNP UniChem_NNP Plc_NNP 50_CD TRANSITION_NNP TO_TO IFRS_NNP CONTINUED_VBD Explanation_NN of_IN adjustments_NNS to_TO conform_VB to_TO IFRS_NNP The_NNP significant_JJ changes_NNS as_IN a_DT result_NN of_IN the_DT transition_NN to_TO IFRS_NNP and_CC of_IN adopting_VBG the_DT IFRS_NNP Group_NNP accounting_NN policies_NNS are_VBP described_VBN below_IN :_: Share-based_JJ compensation_NN Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP ,_, a_DT charge_NN to_TO the_DT profit_NN and_CC loss_NN account_NN was_VBD made_VBN in_IN respect_NN of_IN share-based_JJ compensation_NN schemes_NNS based_VBN on_IN the_DT intrinsic_JJ value_NN of_IN the_DT awards_NNS ._.
Under_IN IFRS_NNP 2_CD Share-based_JJ Payment_NN ,_, a_DT charge_NN to_TO income_NN ,_, representing_VBG the_DT fair_JJ value_NN of_IN outstanding_JJ equity_NN instruments_NNS granted_VBN to_TO employees_NNS under_IN share-based_JJ compensation_NN schemes_NNS ,_, is_VBZ recognized_VBN over_IN the_DT vesting_JJ period_NN of_IN the_DT schemes_NNS ._.
Impact_NN The_DT Groups_NNS principal_JJ share_NN based_VBN compensation_NN schemes_NNS comprise_VBP savings_NNS related_VBN and_CC discretionary_JJ share_NN option_NN schemes_NNS ._.
Under_IN UK_NNP GAAP_NNP ,_, there_EX was_VBD no_DT charge_NN for_IN these_DT share-based_JJ compensation_NN schemes_NNS because_IN they_PRP are_VBP either_RB Inland_NNP Revenue_NNP approved_VBD and_CC therefore_RB specifically_RB excluded_VBN from_IN the_DT requirement_NN to_TO record_VB a_DT charge_NN or_CC have_VBP an_DT intrinsic_JJ value_NN of_IN nil_NN as_IN the_DT option_NN price_NN is_VBZ set_VBN at_IN the_DT market_NN value_NN at_IN the_DT date_NN of_IN grant_NN ._.
The_DT Group_NNP has_VBZ taken_VBN up_RP the_DT option_NN under_IN IFRS_NNP 1_CD permitting_VBG companies_NNS to_TO apply_VB IFRS_NNP 2_CD only_RB to_TO equity_NN instruments_NNS granted_VBN after_IN 7_CD November_NNP 2002_CD that_WDT had_VBD not_RB vested_VBN prior_RB to_TO 1_CD January_NNP 2005_CD ._.
As_IN a_DT result_NN ,_, the_DT share-based_JJ compensation_NN charge_NN in_IN respect_NN of_IN equity_NN settled_VBD compensation_NN was_VBD 2.2_CD million_CD for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD ._.
Goodwill_NN amortisation_NN business_NN combinations_NNS Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP ,_, goodwill_NN was_VBD amortised_VBN over_IN its_PRP$ expected_VBN useful_JJ economic_JJ life_NN ,_, up_RB to_TO a_DT maximum_NN of_IN 20_CD years_NNS ._.
Under_IN IFRS_NNP 3_NNP Business_NNP Combinations_NNPS goodwill_NN is_VBZ not_RB amortised_VBN ._.
Under_IN both_DT UK_NNP GAAP_NNP and_CC IFRS_NNP ,_, the_DT carrying_VBG value_NN of_IN goodwill_NN is_VBZ tested_VBN for_IN impairment_NN and_CC provided_VBN for_IN as_RB necessary_JJ ._.
The_DT Group_NNP has_VBZ carried_VBN out_RP impairment_NN tests_NNS and_CC no_DT adjustment_NN was_VBD deemed_VBN necessary_JJ ._.
IFRS_NNS does_VBZ not_RB allow_VB the_DT recycling_NN of_IN goodwill_NN to_TO the_DT income_NN statement_NN which_WDT was_VBD previously_RB written_VBN off_RP against_IN reserves_NNS ._.
The_DT Group_NNP has_VBZ taken_VBN up_RP the_DT option_NN under_IN IFRS_NNP 1_CD permitting_VBG companies_NNS not_RB to_TO restate_VB past_JJ business_NN combinations_NNS prior_RB to_TO the_DT opening_NN balance_NN sheet_NN date_NN 1_CD January_NNP 2004_CD ._.
Impact_NNP Goodwill_NNP amortisation_NN under_IN UK_NNP GAAP_NNP of_IN 15.1_CD million_CD ,_, comprising_VBG 10.0_CD million_CD in_IN respect_NN of_IN subsidiary_NN undertakings_NNS and_CC 5.1_CD million_CD in_IN respect_NN of_IN associates_NNS ,_, was_VBD added_VBN back_RB to_TO the_DT profit_NN for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD ._.
The_DT exceptional_JJ item_NN under_IN UK_NNP GAAP_NNP in_IN the_DT second_JJ half_NN of_IN 2004_CD relating_VBG to_TO the_DT profit_NN on_IN disposal_NN of_IN businesses_NNS included_VBD 11.1_CD million_CD of_IN capitalized_JJ goodwill_NN and_CC 6.5_CD million_CD of_IN goodwill_NN originally_RB written_VBN off_RP directly_RB to_TO reserves_NNS and_CC recycled_VBN to_TO the_DT profit_NN and_CC loss_NN account_NN as_IN part_NN of_IN the_DT calculation_NN of_IN the_DT profit_NN on_IN disposal_NN ._.
Under_IN IFRS_NNP ,_, the_DT profit_NN on_IN disposal_NN was_VBD increased_VBN by_IN a_DT net_JJ amount_NN of_IN 5.6_CD million_CD ,_, being_VBG a_DT reduction_NN of_IN the_DT 2004_CD amortisation_NN charge_NN of_IN 0.9_CD million_CD deducted_VBN from_IN the_DT capitalized_JJ goodwill_NN disposed_VBD of_IN ,_, and_CC an_DT increase_NN due_JJ to_TO the_DT reversal_NN of_IN the_DT amount_NN of_IN 6.5_CD million_CD of_IN goodwill_NN recycled_VBN from_IN reserves_NNS ._.
Deferred_JJ taxation_NN Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP ,_, deferred_VBN taxation_NN was_VBD provided_VBN in_IN full_JJ on_IN timing_NN differences_NNS which_WDT result_VBP in_IN an_DT obligation_NN at_IN the_DT balance_NN sheet_NN date_NN to_TO pay_VB more_JJR tax_NN ,_, or_CC a_DT right_NN to_TO pay_VB less_JJR tax_NN ,_, at_IN a_DT future_JJ date_NN ,_, at_IN rates_NNS expected_VBN to_TO apply_VB when_WRB they_PRP crystallise_VBP based_VBN on_IN current_JJ tax_NN rates_NNS and_CC law_NN at_IN the_DT balance_NN sheet_NN date_NN ._.
Deferred_JJ taxation_NN was_VBD provided_VBN on_IN remittable_JJ earnings_NNS of_IN associates_NNS only_RB where_WRB there_EX is_VBZ a_DT commitment_NN to_TO remit_VB the_DT earnings_NNS ._.
Deferred_JJ taxation_NN was_VBD not_RB provided_VBN on_IN timing_NN differences_NNS arising_VBG from_IN either_DT rolled_VBN over_IN gains_NNS or_CC the_DT revaluation_NN of_IN fixed_JJ assets_NNS where_WRB there_EX was_VBD no_DT commitment_NN to_TO sell_VB the_DT asset_NN ._.
Under_IN IFRS_NNP ,_, specifically_RB IAS_NNP 12_CD Income_NNP Taxes_NNS ,_, deferred_VBN taxation_NN is_VBZ provided_VBN in_IN full_JJ on_IN all_DT taxable_JJ temporary_JJ differences_NNS ._.
Consequently_RB ,_, IFRS_NNP is_VBZ generally_RB more_RBR comprehensive_JJ in_IN the_DT requirement_NN to_TO recognize_VB deferred_JJ taxation_NN ._.
For_IN example_NN ,_, deferred_VBN taxation_NN is_VBZ provided_VBN on_IN the_DT revaluation_NN of_IN fixed_JJ assets_NNS and_CC rolled_VBD over_IN capital_NN gains_NNS regardless_RB of_IN whether_IN there_EX is_VBZ a_DT commitment_NN to_TO sell_VB the_DT asset_NN ._.
Deferred_JJ taxation_NN is_VBZ provided_VBN on_IN remittable_JJ earnings_NNS of_IN associates_NNS where_WRB incremental_JJ tax_NN would_MD be_VB due_JJ ,_, regardless_RB of_IN whether_IN there_EX is_VBZ a_DT commitment_NN to_TO remit_VB the_DT earnings_NNS ._.
Deferred_JJ taxation_NN is_VBZ also_RB provided_VBN when_WRB retail_JJ pharmacy_NN licences_NNS are_VBP acquired_VBN through_IN the_DT purchase_NN of_IN shares_NNS ,_, regardless_RB of_IN whether_IN there_EX is_VBZ an_DT intention_NN to_TO sell_VB the_DT licences_NNS or_CC not_RB ._.
Impact_NN The_DT most_RBS significant_JJ impact_NN was_VBD on_IN the_DT opening_NN balance_NN sheet_NN where_WRB there_EX was_VBD a_DT reduction_NN in_IN net_JJ assets_NNS of_IN 90.3_CD million_CD as_IN a_DT result_NN of_IN recognizing_VBG additional_JJ deferred_VBN taxation_NN liabilities_NNS ._.
The_DT largest_JJS item_NN was_VBD 67.3_CD million_CD in_IN respect_NN of_IN deferred_VBN taxation_NN liabilities_NNS on_IN pharmacy_NN licences_NNS ,_, which_WDT arose_VBD as_IN a_DT consequence_NN of_IN our_PRP$ decision_NN to_TO take_VB up_RP the_DT exemption_NN not_RB to_TO revisit_VB acquisition_NN accounting_NN prior_RB to_TO the_DT IFRS_NNP transition_NN date_NN ._.
Taking_VBG up_RP the_DT exemption_NN meant_VBD that_IN we_PRP were_VBD required_VBN to_TO recognize_VB this_DT liability_NN as_IN a_DT reduction_NN to_TO equity_NN in_IN the_DT opening_NN IFRS_NNP balance_NN sheet_NN ,_, and_CC as_IN such_JJ it_PRP was_VBD a_DT one_CD off_RP effect_NN ._.
Going_VBG forward_RB ,_, recognition_NN of_IN this_DT type_NN of_IN deferred_VBN taxation_NN liability_NN results_NNS in_IN an_DT increase_NN in_IN capitalized_JJ goodwill_NN ._.
Changes_NNS in_IN taxation_NN rates_NNS and_CC indexation_NN when_WRB applied_VBN to_TO these_DT additional_JJ deferred_JJ taxation_NN liabilities_NNS impact_NN profits_NNS under_IN IFRS_NNP when_WRB compared_VBN to_TO UK_NNP GAAP_NNP ._.
The_DT net_JJ impact_NN of_IN deferred_VBN taxation_NN on_IN the_DT results_NNS of_IN the_DT Group_NNP for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD was_VBD an_DT increase_NN in_IN profits_NNS of_IN 1.5_CD million_CD ._.
The_DT following_JJ section_NN describes_VBZ in_IN more_JJR detail_NN the_DT impact_NN of_IN the_DT more_RBR significant_JJ additional_JJ deferred_VBN taxation_NN liabilities_NNS recognized_VBN under_IN IFRS_NNP ._.
110_CD Alliance_NNP UniChem_NNP Plc_NNP Notes_NNP to_TO the_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD 50_CD TRANSITION_NN TO_TO IFRS_NNP CONTINUED_VBD Explanation_NN of_IN adjustments_NNS to_TO conform_VB to_TO IFRS_NNP continued_VBD Deferred_JJ taxation_NN continued_VBD Impact_NNP continued_VBD Remittable_JJ earnings_NNS of_IN associates_NNS :_: A_DT deferred_VBN taxation_NN charge_NN of_IN 2.6_CD million_CD arising_VBG on_IN remittable_JJ earnings_NNS of_IN associates_NNS was_VBD recognized_VBN in_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD under_IN IFRS_NNP ._.
At_IN 31_CD December_NNP 2004_CD the_DT cumulative_JJ deferred_VBN taxation_NN liability_NN on_IN all_DT such_JJ remittable_JJ earnings_NNS was_VBD 7.4_CD million_CD and_CC at_IN 1_CD January_NNP 2004_CD was_VBD 4.8_CD million_CD ._.
Pharmacy_NNP licences_VBZ :_: When_WRB retail_JJ pharmacies_NNS are_VBP acquired_VBN through_IN the_DT purchase_NN of_IN shares_NNS as_IN opposed_VBN to_TO asset_NN deals_NNS ,_, the_DT Group_NNP acquires_VBZ an_DT asset_NN the_DT licence_NN with_IN a_DT tax_NN base_NN cost_NN significantly_RB lower_JJR than_IN the_DT book_NN value_NN and_CC so_RB a_DT temporary_JJ difference_NN arises_VBZ ._.
The_DT deferred_VBN taxation_NN on_IN this_DT difference_NN is_VBZ recognized_VBN under_IN IFRS_NNP ._.
Under_IN UK_NNP GAAP_NNP ,_, deferred_VBN taxation_NN was_VBD provided_VBN on_IN timing_NN differences_NNS and_CC initial_JJ recognition_NN of_IN pharmacy_NN licences_NNS as_IN a_DT fair_JJ value_NN adjustment_NN does_VBZ not_RB create_VB a_DT timing_NN difference_NN ._.
As_IN noted_VBN ,_, the_DT Group_NNP chose_VBD not_RB to_TO restate_VB business_NN combinations_NNS prior_RB to_TO the_DT IFRS_NNP transition_NN date_NN 1_CD January_NNP 2004_CD ._.
A_DT consequence_NN of_IN this_DT was_VBD that_IN under_IN the_DT transitional_JJ requirements_NNS of_IN IFRS_NNP 1_CD ,_, the_DT deferred_VBN taxation_NN liability_NN on_IN retail_JJ pharmacy_NN licences_NNS required_VBN to_TO be_VB recognized_VBN under_IN IFRS_NNP was_VBD adjusted_VBN through_IN retained_VBN earnings_NNS rather_RB than_IN capitalized_JJ goodwill_NN ._.
For_IN the_DT Group_NNP ,_, the_DT effect_NN of_IN this_DT requirement_NN was_VBD to_TO reduce_VB total_JJ equity_NN under_IN IFRS_NNP at_IN 1_CD January_NNP 2004_CD by_IN 67.3_CD million_CD ,_, being_VBG the_DT deferred_VBN taxation_NN liability_NN in_IN relation_NN to_TO retail_JJ licences_NNS purchased_VBN under_IN share_NN deals_VBZ up_RP to_TO 1_CD January_NNP 2004_CD ._.
The_DT taxation_NN will_MD not_RB be_VB payable_JJ as_RB long_RB as_IN the_DT licences_NNS are_VBP not_RB sold_VBN ._.
From_IN 1_CD January_NNP 2004_CD ,_, the_DT deferred_VBN taxation_NN liability_NN has_VBZ been_VBN recognized_VBN on_IN acquisitions_NNS with_IN a_DT corresponding_JJ increase_NN in_IN capitalized_JJ goodwill_NN ,_, and_CC as_IN such_JJ there_EX is_VBZ no_DT effect_NN on_IN total_JJ equity_NN ._.
As_IN a_DT result_NN of_IN a_DT reduction_NN in_IN the_DT tax_NN rate_NN in_IN The_DT Netherlands_NNP in_IN the_DT second_JJ half_NN of_IN 2004_CD and_CC indexation_NN in_IN the_DT UK_NNP during_IN 2004_CD ,_, the_DT deferred_VBN taxation_NN liability_NN reduced_VBN and_CC a_DT deferred_VBN taxation_NN credit_NN of_IN 2.6_CD million_CD was_VBD recognized_VBN as_IN an_DT adjustment_NN to_TO the_DT profit_NN for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD under_IN IFRS_NNP ._.
After_IN this_DT credit_NN ,_, the_DT effect_NN at_IN 31_CD December_NNP 2004_CD was_VBD to_TO reduce_VB total_JJ equity_NN under_IN IFRS_NNP by_IN 64.7_CD million_CD ._.
Rolled_VBN over_IN capital_NN gains_NNS :_: The_DT requirement_NN to_TO recognize_VB a_DT deferred_JJ tax_NN liability_NN on_IN rolled_VBN over_IN capital_NN gains_NNS regardless_RB of_IN whether_IN there_EX was_VBD a_DT commitment_NN to_TO sell_VB the_DT asset_NN resulted_VBD in_IN a_DT decrease_NN in_IN total_JJ equity_NN at_IN the_DT opening_NN balance_NN sheet_NN date_NN of_IN 14.4_CD million_CD ._.
A_DT deferred_JJ taxation_NN credit_NN of_IN 1.0_CD million_CD was_VBD recognized_VBN in_IN the_DT second_JJ half_NN of_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD as_IN a_DT result_NN of_IN a_DT decrease_NN in_IN the_DT French_JJ capital_NN gains_NNS tax_NN rate_NN from_IN 2005_CD ,_, applied_VBN to_TO the_DT rolled_VBN over_IN capital_NN gains_NNS relating_VBG to_TO fixed_VBN asset_NN investments_NNS held_VBN in_IN France_NNP ._.
This_DT brought_VBD the_DT total_JJ deferred_JJ taxation_NN liability_NN on_IN rolled_VBN over_IN gains_NNS at_IN 31_CD December_NNP 2004_CD to_TO 13.4_CD million_CD ._.
Fixed_JJ asset_NN revaluations_NNS :_: The_DT requirement_NN to_TO recognize_VB a_DT deferred_JJ tax_NN liability_NN on_IN fixed_JJ asset_NN revaluations_NNS regardless_RB of_IN whether_IN there_EX was_VBD a_DT commitment_NN to_TO sell_VB the_DT asset_NN resulted_VBD in_IN a_DT decrease_NN in_IN total_JJ equity_NN at_IN the_DT opening_NN balance_NN sheet_NN of_IN 5.1_CD million_CD ._.
A_DT deferred_JJ taxation_NN credit_NN of_IN 0.5_CD million_CD was_VBD recognized_VBN in_IN the_DT second_JJ half_NN of_IN the_DT year_NN as_IN a_DT result_NN of_IN the_DT disposal_NN of_IN certain_JJ fixed_JJ assets_NNS ._.
This_DT brought_VBD the_DT total_JJ deferred_JJ taxation_NN liability_NN on_IN fixed_JJ asset_NN revaluations_NNS at_IN 31_CD December_NNP 2004_CD to_TO 4.6_CD million_CD ._.
Share-based_JJ compensation_NN charge_NN :_: A_DT deferred_VBN taxation_NN asset_NN is_VBZ recognized_VBN under_IN IFRS_NNP in_IN respect_NN of_IN share-based_JJ compensation_NN ._.
The_DT asset_NN is_VBZ calculated_VBN on_IN the_DT difference_NN between_IN the_DT market_NN price_NN of_IN the_DT Companys_NNP shares_NNS at_IN the_DT balance_NN sheet_NN date_NN and_CC the_DT option_NN price_NN for_IN options_NNS granted_VBN to_TO UK_NNP employees_NNS and_CC results_NNS in_IN an_DT increase_NN in_IN total_JJ equity_NN at_IN the_DT opening_NN balance_NN sheet_NN date_NN of_IN 0.2_CD million_CD ._.
On_IN re-measurement_NN of_IN the_DT deferred_VBN taxation_NN asset_NN ,_, an_DT element_NN of_IN this_DT is_VBZ taken_VBN to_TO the_DT income_NN statement_NN under_IN IFRS_NNP ,_, which_WDT amounts_VBZ to_TO a_DT 0.5_CD million_CD deferred_VBN taxation_NN credit_NN in_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD ,_, and_CC the_DT remainder_NN is_VBZ taken_VBN directly_RB to_TO reserves_NNS ._.
As_IN at_IN 31_CD December_NNP 2004_CD the_DT cumulative_JJ deferred_VBN taxation_NN asset_NN on_IN all_DT such_JJ options_NNS was_VBD 1.2_CD million_CD ._.
Dividends_NNS Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP ,_, dividends_NNS proposed_VBN were_VBD provided_VBN for_IN in_IN the_DT period_NN to_TO which_WDT they_PRP related_VBD ._.
Under_IN IFRS_NNP ,_, dividends_NNS are_VBP only_RB provided_VBN for_IN when_WRB the_DT dividend_NN has_VBZ been_VBN declared_VBN ._.
Impact_NN The_DT requirement_NN to_TO provide_VB for_IN dividends_NNS only_RB when_WRB they_PRP are_VBP declared_VBN resulted_VBD in_IN an_DT increase_NN in_IN total_JJ equity_NN of_IN 38.1_CD million_CD at_IN the_DT opening_NN balance_NN sheet_NN date_NN and_CC an_DT increase_NN of_IN 43.5_CD million_CD at_IN 31_CD December_NNP 2004_CD ._.
Consolidation_NN of_IN special_JJ purpose_NN entities_NNS Principal_NN difference_NN The_DT Group_NNP runs_VBZ securitisation_NN programs_NNS in_IN the_DT UK_NNP ,_, France_NNP and_CC Italy_NNP whereby_WRB it_PRP sells_VBZ certain_JJ trade_NN receivables_NN and_CC receives_VBZ an_DT initial_JJ cash_NN payment_NN on_IN a_DT non-recourse_JJ basis_NN in_IN return_NN ._.
The_DT securitised_JJ receivables_NN are_VBP purchased_VBN by_IN special_JJ purpose_NN entities_NNS which_WDT under_IN UK_NNP GAAP_NNP were_VBD not_RB consolidated_JJ ._.
Under_IN SIC-12_NNP Consolidation_NN Special_JJ Purpose_NN Entities_NNS ,_, special_JJ purpose_NN entities_NNS shall_MD be_VB consolidated_VBN when_WRB the_DT substance_NN of_IN the_DT relationship_NN with_IN the_DT reporting_NN entity_NN indicates_VBZ that_IN the_DT special_JJ purpose_NN entities_NNS are_VBP controlled_VBN by_IN the_DT reporting_NN entity_NN ._.
The_DT substance_NN of_IN the_DT relationship_NN with_IN the_DT special_JJ purpose_NN entities_NNS in_IN the_DT UK_NNP and_CC in_IN Italy_NNP requires_VBZ those_DT entities_NNS to_TO be_VB consolidated_VBN ._.
On_IN the_DT basis_NN that_IN the_DT Group_NNP does_VBZ not_RB meet_VB the_DT control_NN indicators_NNS set_VBN out_RP in_IN SIC-12_NN there_EX is_VBZ no_DT requirement_NN to_TO consolidate_VB the_DT French_JJ special_JJ purpose_NN entity_NN ._.
Impact_NN The_DT consolidation_NN of_IN the_DT UK_NNP and_CC Italian_JJ special_JJ purpose_NN entities_NNS had_VBD the_DT effect_NN of_IN eliminating_VBG from_IN operating_NN expenses_NNS fixed_VBN charges_NNS of_IN 0.8_CD million_CD for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD and_CC increasing_VBG finance_NN costs_NNS by_IN 0.8_CD million_CD for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD ._.
There_EX was_VBD no_DT impact_NN on_IN profits_NNS resulting_VBG from_IN this_DT change_NN ,_, which_WDT is_VBZ merely_RB a_DT reclassification_NN within_IN the_DT financial_JJ statements_NNS ._.
111_CD Alliance_NNP UniChem_NNP Plc_NNP 50_CD TRANSITION_NNP TO_TO IFRS_NNP CONTINUED_VBD Explanation_NN of_IN adjustments_NNS to_TO conform_VB to_TO IFRS_NNP continued_VBD Computer_NNP software_NN Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP ,_, the_DT Groups_NNS capitalized_VBN computer_NN software_NN was_VBD included_VBN within_IN tangible_JJ fixed_JJ assets_NNS ,_, whereas_IN under_IN IFRS_NNP it_PRP is_VBZ classified_VBN as_IN an_DT intangible_JJ asset_NN ._.
Impact_NN At_IN the_DT opening_NN balance_NN sheet_NN date_NN ,_, computer_NN software_NN with_IN a_DT net_JJ book_NN value_NN of_IN 14.7_CD million_CD was_VBD reclassified_VBN from_IN tangible_JJ fixed_JJ assets_NNS to_TO intangible_JJ assets_NNS ._.
At_IN 31_CD December_NNP 2004_CD the_DT net_NN book_NN value_NN reclassified_VBD was_VBD 23.9_CD million_CD ._.
Depreciation_NN amounting_NN to_TO 5.0_CD million_CD was_VBD reclassified_VBN as_IN amortisation_NN under_IN IFRS_NNP in_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD ._.
Other_JJ reclassifications_NNS Principal_NN differences_NNS The_DT other_JJ significant_JJ reclassifications_NNS for_IN the_DT Group_NNP under_IN IFRS_NNP compared_VBN to_TO UK_NNP GAAP_NNP were_VBD as_IN follows_VBZ :_: items_NNS that_WDT were_VBD treated_VBN as_IN non-operating_JJ exceptional_JJ items_NNS under_IN UK_NNP GAAP_NNP and_CC relate_VB to_TO continuing_VBG operations_NNS are_VBP included_VBN in_IN arriving_VBG at_IN profit_NN from_IN operations_NNS :_: and_CC the_DT Groups_NNS share_NN of_IN the_DT results_NNS of_IN associates_NNS are_VBP now_RB shown_VBN on_IN a_DT single_JJ line_NN in_IN the_DT income_NN statement_NN ._.
Adoption_NN of_IN IAS_NNP 32_CD Financial_NNP Instruments_NNPS :_: Disclosure_NN and_CC Presentation_NN and_CC IAS_NNP 39_CD Financial_NNP Instruments_NNPS :_: Recognition_NN and_CC Measurement_NNP The_NNP Group_NNP has_VBZ chosen_VBN not_RB to_TO restate_VB comparatives_NNS for_IN IAS_NNP 32_CD and_CC IAS_NNP 39_CD ,_, and_CC is_VBZ applying_VBG these_DT standards_NNS with_IN effect_NN from_IN 1_CD January_NNP 2005_CD ._.
As_IN a_DT result_NN ,_, the_DT relevant_JJ 2004_CD comparative_JJ information_NN does_VBZ not_RB reflect_VB the_DT impact_NN of_IN these_DT standards_NNS and_CC is_VBZ accounted_VBN for_IN and_CC presented_VBN on_IN a_DT UK_NNP GAAP_NNP basis_NN ._.
Set_VBN out_RP below_IN are_VBP the_DT significant_JJ areas_NNS where_WRB the_DT Group_NNP was_VBD affected_VBN from_IN 1_CD January_NNP 2005_CD ,_, which_WDT are_VBP predominantly_RB around_IN the_DT presentation_NN of_IN the_DT balance_NN sheet_NN ._.
Securitised_JJ receivables_NN Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP linked_VBD presentation_NN was_VBD used_VBN by_IN the_DT Group_NNP to_TO record_VB receivables_NN sold_VBN and_CC non-recourse_JJ receipts_NNS received_VBN in_IN respect_NN of_IN securitisation_NN programs_NNS in_IN the_DT UK_NNP ,_, France_NNP and_CC Italy_NNP ._.
Under_IN IAS_NNP 32_CD and_CC IAS_NNP 39_CD ,_, linked_VBN presentation_NN is_VBZ no_RB longer_RB permitted_VBN and_CC the_DT non-recourse_JJ receipts_NNS are_VBP to_TO be_VB reported_VBN separately_RB within_IN liabilities_NNS ._.
As_IN a_DT result_NN of_IN the_DT Groups_NNS decision_NN not_RB to_TO restate_VB comparatives_NNS for_IN IAS_NNP 32_CD and_CC IAS_NNP 39_CD ,_, the_DT non-recourse_JJ receipts_NNS in_IN the_DT balance_NN sheet_NN presented_VBN in_IN the_DT comparative_JJ information_NN are_VBP presented_VBN under_IN the_DT UK_NNP GAAP_NNP basis_NN of_IN linked_VBN presentation_NN ._.
Impact_NN Liabilities_NNS will_MD include_VB amounts_NNS relating_VBG to_TO non-recourse_JJ receipts_NNS received_VBN in_IN respect_NN of_IN securitisation_NN programs_NNS ._.
Based_VBN on_IN the_DT position_NN at_IN 31_CD December_NNP 2004_CD ,_, this_DT amounted_VBD to_TO 400.8_CD million_CD in_IN the_DT 2005_CD opening_NN balance_NN sheet_NN ._.
There_EX is_VBZ no_DT impact_NN on_IN reserves_NNS resulting_VBG from_IN these_DT changes_NNS ,_, which_WDT are_VBP merely_RB reclassifications_NNS within_IN the_DT balance_NN sheet_NN ._.
Derivative_JJ instruments_NNS and_CC hedging_VBG activities_NNS Principal_NN difference_NN Under_IN IAS_NNP 32_CD and_CC IAS_NNP 39_CD ,_, all_DT derivative_JJ instruments_NNS are_VBP recognized_VBN in_IN the_DT balance_NN sheet_NN as_IN financial_JJ assets_NNS or_CC financial_JJ liabilities_NNS and_CC are_VBP recorded_VBN at_IN their_PRP$ fair_JJ value_NN ._.
The_DT change_NN in_IN the_DT fair_JJ value_NN of_IN a_DT derivative_JJ instrument_NN is_VBZ taken_VBN immediately_RB to_TO the_DT income_NN statement_NN where_WRB ,_, provided_VBD fair_JJ value_NN hedge_NN accounting_NN can_MD be_VB applied_VBN ,_, it_PRP will_MD be_VB offset_VBN by_IN a_DT change_NN in_IN the_DT fair_JJ value_NN of_IN the_DT related_JJ hedged_VBN item_NN ._.
If_IN the_DT derivative_NN is_VBZ hedging_VBG the_DT variability_NN of_IN future_JJ cash_NN flows_NNS in_IN a_DT cash_NN flow_NN hedge_NN which_WDT meet_VBP the_DT hedging_VBG criteria_NNS ,_, the_DT change_NN in_IN the_DT fair_JJ value_NN of_IN the_DT derivative_NN is_VBZ taken_VBN directly_RB to_TO reserves_NNS and_CC is_VBZ subsequently_RB recycled_VBN to_TO the_DT income_NN statement_NN when_WRB the_DT hedged_VBN cash_NN flow_NN impacts_VBZ profit_NN and_CC loss_NN ._.
The_DT ineffective_JJ portions_NNS are_VBP taken_VBN immediately_RB to_TO the_DT income_NN statement_NN ._.
The_DT Group_NNP uses_VBZ a_DT mixture_NN of_IN debt_NN and_CC derivative_JJ financial_JJ instruments_NNS to_TO hedge_VB its_PRP$ non-sterling_JJ investments_NNS ._.
The_DT effective_JJ portion_NN of_IN the_DT change_NN in_IN fair_JJ value_NN of_IN the_DT hedging_VBG instrument_NN is_VBZ taken_VBN to_TO reserves_NNS and_CC is_VBZ subsequently_RB recycled_VBN to_TO the_DT income_NN statement_NN when_WRB the_DT Groups_NNS investment_NN is_VBZ disposed_VBN of_IN ._.
The_DT ineffective_JJ portion_NN is_VBZ taken_VBN immediately_RB to_TO the_DT income_NN statement_NN ._.
Impact_NN The_DT effective_JJ date_NN of_IN adoption_NN of_IN IAS_NNP 32_CD and_CC IAS_NNP 39_CD for_IN the_DT Group_NNP is_VBZ 1_CD January_NNP 2005_CD ._.
Excluding_VBG the_DT impact_NN of_IN the_DT grossing_VBG up_IN of_IN the_DT securitised_JJ receivables_NN as_IN discussed_VBN above_IN ,_, the_DT financial_JJ liabilities_NNS in_IN the_DT opening_NN balance_NN sheet_NN in_IN 2005_CD increased_VBN by_IN 22.3_CD million_CD ,_, offset_VBN by_IN related_JJ deferred_VBN taxation_NN of_IN 6.7_CD million_CD ,_, giving_VBG a_DT net_JJ reduction_NN to_TO total_JJ equity_NN of_IN 15.6_CD million_CD ._.
Available-for-sale_JJ financial_JJ assets_NNS Principal_NN difference_NN Under_IN UK_NNP GAAP_NNP ,_, listed_VBN investments_NNS are_VBP recorded_VBN on_IN the_DT balance_NN sheet_NN at_IN the_DT lower_JJR of_IN cost_NN and_CC realisable_JJ value_NN ._.
Under_IN IAS_NNP 32_CD and_CC IAS_NNP 39_CD ,_, the_DT Groups_NNS listed_VBN investments_NNS are_VBP categorised_VBN as_IN available-for-sale_JJ and_CC are_VBP recorded_VBN at_IN fair_JJ value_NN ._.
Changes_NNS in_IN fair_JJ value_NN ,_, together_RB with_IN any_DT related_JJ deferred_JJ taxation_NN ,_, are_VBP taken_VBN directly_RB to_TO reserves_NNS and_CC are_VBP recycled_VBN to_TO the_DT income_NN statement_NN when_WRB the_DT investment_NN is_VBZ sold_VBN or_CC is_VBZ determined_VBN to_TO be_VB impaired_VBN ._.
The_DT financial_JJ assets_NNS in_IN the_DT opening_NN balance_NN sheet_NN in_IN 2005_CD increased_VBN by_IN 3.9_CD million_CD due_JJ to_TO the_DT recognition_NN of_IN listed_VBN investments_NNS at_IN fair_JJ value_NN ,_, which_WDT together_RB with_IN the_DT related_JJ deferred_JJ taxation_NN liability_NN of_IN 0.4_CD million_CD gave_VBD a_DT net_JJ increase_NN to_TO total_JJ equity_NN of_IN 3.5_CD million_CD ._.
112_CD Alliance_NNP UniChem_NNP Plc_NNP Notes_NNP to_TO the_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD 50_CD TRANSITION_NN TO_TO IFRS_NNP CONTINUED_VBD Reconciliation_NNP of_IN equity_NN at_IN 1_CD January_NNP 2004_CD Other_JJ and_CC reclassifiUK_NNP GAAP_NNP IAS_NNP 12_CD IAS_NNP 37_CD cations_NNS IFRS_CD million_CD million_CD million_CD million_CD million_CD Assets_NNS Non-current_JJ assets_NNS Goodwill_NNP 172.3_CD 172.3_CD Intangible_JJ assets_NNS 612.4_CD 14.7_CD 627.1_CD Property_NN ,_, plant_NN and_CC equipment_NN 304.9_CD 15.6_CD 289.3_CD Investments_NNP in_IN associates_NNS 240.9_CD 240.9_CD Loans_NNS to_TO associates_NNS 46.7_CD 46.7_CD Other_JJ investments_NNS 60.3_CD 60.3_CD Deferred_JJ tax_NN assets_NNS 3.0_CD 1.1_CD 4.1_CD Trade_NNP and_CC other_JJ receivables_NN 41.0_CD 41.0_CD 1,481.5_CD 1.1_CD 0.9_CD 1,481.7_CD Current_JJ assets_NNS Inventories_NNS 728.8_CD 728.8_CD Securitised_JJ receivables_NN 448.8_CD 448.8_CD Non-recourse_NN receipts_NNS 399.5_CD 399.5_CD Net_JJ securitised_JJ receivables_NN 49.3_CD 49.3_CD Trade_NNP and_CC other_JJ receivables_NN 1,084.6_CD 1.1_CD 1,083.5_CD Cash_NN and_CC cash_NN equivalents_NNS 117.2_CD 0.8_CD 118.0_CD 1,979.9_CD 0.3_CD 1,979.6_CD Non-current_JJ assets_NNS classified_VBN as_IN held_VBN for_IN sale_NN 1.8_CD 1.8_CD Total_JJ assets_NNS 3,461.4_CD 1.1_CD 0.6_CD 3,463.1_CD Liabilities_NNP Current_NNP liabilities_NNS Financial_NNP liabilities_NNS borrowings_NNS 257.5_CD 257.5_CD Trade_NNP and_CC other_JJ payables_NNS 1,500.2_CD 38.1_CD 0.8_CD 1,462.9_CD Current_JJ corporate_JJ tax_NN liabilities_NNS 23.6_CD 23.6_CD 1,781.3_CD 38.1_CD 0.8_CD 1,744.0_CD Net_JJ current_JJ assets_NNS 198.6_CD 38.1_CD 1.1_CD 235.6_CD Non-current_JJ liabilities_NNS Financial_JJ liabilities_NNS borrowings_NNS 686.9_CD 686.9_CD Deferred_JJ tax_NN liabilities_NNS 3.6_CD 91.8_CD 0.4_CD 95.0_CD Retirement_NNP benefit_NN obligations_NNS 49.3_CD 0.5_CD 49.8_CD 739.8_CD 91.8_CD 0.1_CD 831.7_CD Net_JJ assets_NNS 940.3_CD 90.7_CD 38.1_CD 0.3_CD 887.4_CD Equity_NN Share_NN capital_NN 35.1_CD 35.1_CD Share_NN premium_NN 444.2_CD 444.2_CD Shares_NNS to_TO be_VB issued_VBN 25.1_CD 25.1_CD Employee_NN share_NN trusts_NNS 23.1_CD 23.1_CD Retained_VBN earnings_NNS 445.9_CD 90.7_CD 38.1_CD 0.3_CD 393.0_CD Other_JJ reserves_NNS 2.6_CD 2.6_CD Shareholders_NNS equity_NN 929.8_CD 90.7_CD 38.1_CD 0.3_CD 876.9_CD Minority_NNP interests_NNS 10.5_CD 10.5_CD Total_JJ equity_NN 940.3_CD 90.7_CD 38.1_CD 0.3_CD 887.4_CD 113_CD Alliance_NNP UniChem_NNP Plc_NNP 50_CD TRANSITION_NNP TO_TO IFRS_NNP CONTINUED_VBD Reconciliation_NNP of_IN equity_NN at_IN 31_CD December_NNP 2004_CD Other_JJ and_CC IFRS_JJ 3_CD IFRS_NNS 3_CD reclassifiUK_NNP GAAP_NNP amortisation_NN disposals_NNS IAS_NNP 12_CD IAS_NNP 37_CD cations_NNS IFRS_CD million_CD million_CD million_CD million_CD million_CD million_CD million_CD Assets_NNS Non-current_JJ assets_NNS Goodwill_NNP 157.2_CD 10.0_CD 0.9_CD 8.9_CD 0.4_CD 175.6_CD Intangible_JJ assets_NNS 691.5_CD 23.9_CD 715.4_CD Property_NN ,_, plant_NN and_CC equipment_NN 334.4_CD 0.1_CD 28.5_CD 306.0_CD Investments_NNP in_IN associates_NNS 327.3_CD 5.1_CD 332.4_CD Loans_NNS to_TO associates_NNS 42.5_CD 42.5_CD Other_JJ investments_NNS 42.6_CD 42.6_CD Deferred_JJ tax_NN assets_NNS 5.8_CD 2.1_CD 0.1_CD 7.8_CD Trade_NNP and_CC other_JJ receivables_NN 40.2_CD 40.2_CD 1,641.5_CD 15.1_CD 0.8_CD 11.0_CD 4.3_CD 1,662.5_CD Current_JJ assets_NNS Inventories_NNS 692.2_CD 692.2_CD Securitised_JJ receivables_NN 456.1_CD 456.1_CD Non-recourse_NN receipts_NNS 400.8_CD 400.8_CD Net_JJ securitised_JJ receivables_NN 55.3_CD 55.3_CD Trade_NNP and_CC other_JJ receivables_NN 1,027.6_CD 0.5_CD 1,027.1_CD Cash_NN and_CC cash_NN equivalents_NNS 100.9_CD 1.0_CD 101.9_CD 1,876.0_CD 0.5_CD 1,876.5_CD Non-current_JJ assets_NNS classified_VBN as_IN held_VBN for_IN sale_NN 0.1_CD 1.8_CD 1.7_CD Total_JJ assets_NNS 3,517.5_CD 15.1_CD 0.9_CD 11.0_CD 2.0_CD 3,540.7_CD Liabilities_NNP Current_NNP liabilities_NNS Financial_NNP liabilities_NNS borrowings_NNS 175.8_CD 0.1_CD 175.7_CD Trade_NNP and_CC other_JJ payables_NNS 1,425.0_CD 43.5_CD 1.8_CD 1,383.3_CD Current_JJ corporate_JJ tax_NN liabilities_NNS 37.5_CD 37.5_CD 1,638.3_CD 43.5_CD 1.7_CD 1,596.5_CD Net_JJ current_JJ assets_NNS 237.7_CD 43.5_CD 1.2_CD 280.0_CD Non-current_JJ liabilities_NNS Financial_JJ liabilities_NNS borrowings_NNS 736.1_CD 4.1_CD 732.0_CD Deferred_JJ tax_NN liabilities_NNS 9.1_CD 99.7_CD 0.4_CD 108.4_CD Retirement_NNP benefit_NN obligations_NNS 52.5_CD 0.5_CD 53.0_CD 797.7_CD 99.7_CD 4.0_CD 893.4_CD Net_JJ assets_NNS 1,081.5_CD 15.1_CD 0.9_CD 88.7_CD 43.5_CD 0.3_CD 1,050.8_CD Equity_NN Share_NN capital_NN 35.8_CD 35.8_CD Share_NN premium_NN 485.7_CD 485.7_CD Employee_NN share_NN trusts_NNS 13.1_CD 13.1_CD Retained_VBN earnings_NNS 560.0_CD 15.1_CD 0.9_CD 88.7_CD 43.5_CD 8.2_CD 520.8_CD Translation_NN reserve_NN 8.5_CD 8.5_CD Other_JJ reserves_NNS 2.7_CD 2.7_CD Shareholders_NNS equity_NN 1,071.1_CD 15.1_CD 0.9_CD 88.7_CD 43.5_CD 0.3_CD 1,040.4_CD Minority_NNP interests_NNS 10.4_CD 10.4_CD Total_JJ equity_NN 1,081.5_CD 15.1_CD 0.9_CD 88.7_CD 43.5_CD 0.3_CD 1,050.8_CD 114_CD Alliance_NNP UniChem_NNP Plc_NNP Notes_NNP to_TO the_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD 50_CD TRANSITION_NN TO_TO IFRS_NNP CONTINUED_VBD Reconciliation_NNP of_IN profit_NN for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD Associates_NNPS reclassifiUK_NNP GAAP_NNP IFRS_NNPS 2_CD IFRS_NNS 3_CD IAS_NNP 12_CD cation_NN Other_JJ IFRS_CD million_CD million_CD million_CD million_CD million_CD million_CD million_CD Revenue_NN including_VBG share_NN of_IN associates_NNS revenue_NN 10,605.9_CD 10,605.9_CD Less_RBR :_: share_NN of_IN associates_NNS revenue_NN 1,707.5_CD 1,707.5_CD Revenue_NN 8,898.4_CD 8,898.4_CD Operating_NN profit_NN including_VBG share_NN of_IN associates_NNS operating_VBG profit_NN 275.9_CD 2.2_CD 15.1_CD 0.9_CD 289.7_CD Less_RBR :_: share_NN of_IN associates_NNS operating_VBG profit_NN 41.0_CD 5.1_CD 46.1_CD Operating_NN profit_NN 234.9_CD 2.2_CD 10.0_CD 0.9_CD 243.6_CD Share_NN of_IN associates_NNS operating_VBG profit_NN 41.0_CD 5.1_CD 46.1_CD Share_NN of_IN associates_NNS post_VBP tax_NN earnings_NNS 34.0_CD 34.0_CD Profit_NN on_IN disposal_NN of_IN businesses_NNS 13.6_CD 5.6_CD 19.2_CD Amounts_NNS written_VBN off_RP investments_NNS 1.9_CD 1.9_CD Profit_NN from_IN operations_NNS 287.6_CD 2.2_CD 20.7_CD 12.1_CD 0.9_CD 294.9_CD Finance_NNP income_NN 14.3_CD 6.4_CD 0.1_CD 8.0_CD Finance_NNP costs_NNS 53.7_CD 4.6_CD 0.8_CD 49.9_CD Profit_NN before_IN tax_NN 248.2_CD 2.2_CD 20.7_CD 13.9_CD 0.2_CD 253.0_CD Tax_NNP 81.0_CD 1.5_CD 14.2_CD 65.3_CD Profit_NN for_IN the_DT year_NN 167.2_CD 2.2_CD 20.7_CD 1.5_CD 0.3_CD 0.2_CD 187.7_CD Attributable_JJ to_TO :_: Equity_NNP shareholders_NNS 167.1_CD 2.2_CD 20.7_CD 1.5_CD 0.2_CD 187.3_CD Minority_NNP interests_NNS 0.1_CD 0.3_CD 0.4_CD 167.2_CD 2.2_CD 20.7_CD 1.5_CD 0.3_CD 0.2_CD 187.7_CD Explanation_NN of_IN material_NN adjustments_NNS to_TO the_DT cash_NN flow_NN statement_NN for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD The_DT cash_NN flow_NN statement_NN for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD is_VBZ presented_VBN on_IN page_NN 68_CD ._.
The_DT material_NN adjustments_NNS caused_VBN by_IN the_DT transition_NN to_TO IFRS_NNP on_IN the_DT cash_NN flow_NN statement_NN for_IN that_DT year_NN were_VBD as_IN follows_VBZ :_: 1_LS ._.
Tax_NNP paid_VBD is_VBZ classified_VBN as_IN an_DT operating_NN cash_NN flow_NN under_IN IFRS_NNP ,_, whereas_IN under_IN UK_NNP GAAP_NNP this_DT was_VBD shown_VBN as_IN a_DT separate_JJ category_NN of_IN cash_NN flow_NN ._.
Interest_NN paid_VBN is_VBZ classified_VBN as_IN an_DT operating_NN cash_NN flow_NN under_IN IFRS_NNP ,_, whereas_IN under_IN UK_NNP GAAP_NNP this_DT was_VBD shown_VBN within_IN the_DT returns_NNS on_IN investments_NNS category_NN ._.
Dividends_NNS received_VBD from_IN associates_NNS are_VBP classified_VBN within_IN investing_VBG activities_NNS under_IN IFRS_NNP ,_, whereas_IN under_IN UK_NNP GAAP_NNP this_DT was_VBD shown_VBN as_IN a_DT separate_JJ category_NN of_IN cash_NN flow_NN ._.
Cash_NN flows_VBZ arising_VBG from_IN acquisitions_NNS and_CC disposals_NNS are_VBP classified_VBN within_IN investing_VBG activities_NNS under_IN IFRS_NNP ,_, whereas_IN under_IN UK_NNP GAAP_NNP these_DT were_VBD shown_VBN as_IN a_DT separate_JJ category_NN of_IN cash_NN flow_NN ._.
Cash_NN flows_VBZ arising_VBG from_IN capital_NN expenditure_NN and_CC financial_JJ investment_NN are_VBP classified_VBN within_IN investing_VBG activities_NNS under_IN IFRS_NNP ,_, whereas_IN under_IN UK_NNP GAAP_NNP these_DT were_VBD shown_VBN as_IN a_DT separate_JJ category_NN of_IN cash_NN flow_NN ._.
Dividends_NNS paid_VBD to_TO equity_NN shareholders_NNS are_VBP classified_VBN within_IN financing_NN activities_NNS under_IN IFRS_NNP ,_, whereas_IN under_IN UK_NNP GAAP_NNP these_DT were_VBD shown_VBN as_IN a_DT separate_JJ category_NN of_IN cash_NN flow_NN ._.
The_DT definition_NN of_IN cash_NN and_CC cash_NN equivalents_NNS under_IN IFRS_NNP includes_VBZ money_NN market_NN borrowings_NNS maturing_VBG within_IN one_CD week_NN ._.
Beneath_IN the_DT IFRS_NNP cash_NN flow_NN statement_NN a_DT reconciliation_NN of_IN the_DT increase_NN in_IN cash_NN and_CC cash_NN equivalents_NNS to_TO net_JJ borrowings_NNS is_VBZ provided_VBN ._.
Under_IN IFRS_NNP ,_, net_JJ borrowings_NNS are_VBP defined_VBN by_IN the_DT Group_NNP as_IN borrowings_NNS net_NN of_IN cash_NN and_CC cash_NN equivalents_NNS and_CC derivative_JJ financial_JJ instruments_NNS ._.
This_DT definition_NN is_VBZ consistent_JJ with_IN the_DT definition_NN of_IN net_JJ borrowings_NNS under_IN UK_NNP GAAP_NNP ._.
The_DT only_JJ significant_JJ difference_NN between_IN the_DT net_JJ borrowings_NNS amount_NN at_IN 31_CD December_NNP 2004_CD between_IN IFRS_NNP and_CC UK_NNP GAAP_NNP is_VBZ in_IN respect_NN of_IN the_DT land_NN element_NN of_IN certain_JJ leases_NNS for_IN land_NN and_CC buildings_NNS ._.
Under_IN UK_NNP GAAP_NNP these_DT were_VBD treated_VBN wholly_RB as_IN finance_NN leases_NNS ,_, whilst_NN under_IN IFRS_NNP it_PRP is_VBZ necessary_JJ to_TO split_VB out_RP the_DT land_NN from_IN the_DT building_NN element_NN and_CC consider_VB these_DT separately_RB ._.
In_IN some_DT instances_NNS ,_, under_IN IFRS_NNP the_DT land_NN element_NN no_RB longer_RB met_VBD the_DT definition_NN of_IN a_DT finance_NN lease_NN and_CC is_VBZ accounted_VBN for_IN as_IN an_DT operating_NN lease_NN ._.
The_DT effect_NN of_IN this_DT different_JJ treatment_NN is_VBZ to_TO decrease_VB net_JJ borrowings_NNS under_IN IFRS_NNP by_IN 4.2_CD million_CD at_IN 31_CD December_NNP 2004_CD ._.
The_DT total_JJ decrease_NN in_IN net_JJ borrowings_NNS under_IN IFRS_NNP at_IN 31_CD December_NNP 2004_CD was_VBD 5.2_CD million_CD ._.
